Home › Drug Codes › J Codes › J3380 · ENTYVIO
Updated July 1st, 2026

ENTYVIO J Code: J3380

Injection, vedolizumab, intravenous, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J3380, effective October 1, 2026: $20.949 per HCPCS billing unit, down 3.1% from $21.622. From CMS's final file.

?
Medicare Payment Limit ?
$21.622
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$21.622
/ HCPCS billing unit · APC 1489
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, vedolizumab, intravenous, 1 mg
HCPCS Added Date January 1, 2016
Manufacturer Takeda Pharmaceuticals
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About ENTYVIO

Entyvio is a medication aligned to the HCPCS J Code: J3380 for billing, pricing, and reimbursement purposes in the United States. Classified under Immunology, it is administered via the intravenous route and manufactured by Takeda Pharmaceuticals.

According to CMS Drug Use Information: This medication is used to treat certain bowel disorders (ulcerative colitis, Crohn's disease). In these conditions, the body's defense system (immune system) attacks healthy tissues in the gut, causing symptoms such as abdominal pain, blood in the stool, and diarrhea. Vedolizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking the actions of a certain natural substance (integrin) in the body. This helps to decrease swelling (inflammation) in the gut, which lessens symptoms and may slow or stop damage from these bowel disorders.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
64764-0300-20 Entyvio Takeda Pharmaceuticals America, Inc. 300 300 MG / 5 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ENTYVIO Pricing & Reimbursement

J3380 Private Payer Reimbursement
$21.40 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

ENTYVIO Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 14.08%
Avg. Days to File 6.8days
Avg. Days to Pay 21.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J3380 claims analytics on FocalPoint →
OnPoint Oncology

ENTYVIO CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
96372 Login for More Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular Login for More
JW / JZ modifiers apply

CMS has identified Entyvio (J3380) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

ENTYVIO Medically Unlikely Edits (MUE)

The most billing units of J3380 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
300 units / day
= 300 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

ENTYVIO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Crohn's Disease Ulcerative Colitis
Drug Class
Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Entyvio billing and coding guide?
Billing and coding information for ENTYVIO can be found through Takeda. Visit Here →
Are there any available Entyvio patient assistance programs?
ENTYVIO patient assistance information can be found through Takeda. Visit Here →
Where can I find Entyvio prescribing information?
ENTYVIO prescribing information can be found at the link below: Visit Here →
Where can I find Entyvio side effect information?
Information regarding ENTYVIO's side effects can be found at MedlinePlus Visit Here →
Does billing ENTYVIO require JZ/JW wastage modifiers?
CMS has identified ENTYVIO(J3380) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to ENTYVIO.

J3358STELARAUstekinumab, for intravenous injection, 1 mgJanssenAdded January 1, 2018Q5098IMULDOSAInjection, ustekinumab-srlf (imuldosa), biosimilar, 1 mgAccordAdded July 1, 2025Q5099STEQEYMAInjection, ustekinumab-stba (steqeyma), biosimilar, 1 mgCelltrion USAAdded July 1, 2025Q5100YESINTEKInjection, ustekinumab-kfce (yesintek), biosimilar, 1 mgBiocon Biologics IncAdded July 1, 2025Q5137WezlanaInjection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mgNuvailaAdded July 1, 2024Q5164StarjemzaInjection, ustekinumab-hmny (starjemza), biosimilar, 1 mgHikmaAdded July 1, 2026Q9996PYZCHIVAInjection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mgCordavis LimitedAdded January 1, 2025Q9997PYZCHIVAInjection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mgQuallent PharmaceuticalsAdded January 1, 2025Q9998SELARSDIInjection, ustekinumab-aekn (selarsdi), biosimilar, 1 mgTevaAdded January 1, 2025Q9999OtulfiInjection, ustekinumab-aauz (otulfi), biosimilar, 1 mgFresenius KabiAdded April 1, 2025